Samsung Medison is garnering attention from the global medical community with its ultrasound diagnostic solutions across the women’s life stage from fetal stage to menopause.
At the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) in Cancún, Mexico on September 14, Samsung Medison will showcase its comprehensive women’s health solution under the theme “From Challenges to Solutions: Experience the Innovation.”
From Fetal Stage to Menopause Ultrasound Solution Demonstration Tailored to Women’s Life Stages
The highlight of upgraded HERA Z20, to be unveiled at ISUOG, features diagnostics tailored to every life stage of women. It supports healthcare professionals in managing women’s health comprehensively with a single equipment, enabling dedicated management of women’s health across all stages, from adolescent gynecological conditions and fertility to maternity and aging.
Newly added PelvicAssist™ and three types of reporting features propose diagnostic support innovation for the women and healthcare professionals whom have difficulties due to the gynecological conditions. PelvicAssist™ automatically analyzes multiple pelvic regions and measures the levator hiatus area, providing the 3D image.
Due to the complexity of anatomical structures, considerable time is required to precisely assess and report lesion location, size, shape and degree of invasion. In response, Samsung Medison has unveiled tailored diagnostic reporting solution based on standardized clinical guidelines.
Fibroid 2D, which simplifies the reporting procedure for uterine fibroid by applying The International Federation of Gynecology and Obstetrics (FIGO) guideline. IDEA and IETA highly enhanced diagnostic workflow efficiency by supporting scan procedures and reporting based on guidelines for endometriosis and endometrial tumor evaluation, respectively.
The ultra-compact probe Mini ER7, developed to minimize patient discomfort during gynecological examinations by offering 63% smaller head compared to conventional probes, it is expected to significantly reduce the burden for adolescent and elderly patients.
Ultrasound Solutions for High-risk Pregnancy Care and Enhanced Clinical Efficiency
With maternal age on the rise, high-risk pregnancies are becoming common. In response to this social challenge, Samsung Medison has integrated Ophthalmic Artery feature to detect systemic vasoconstriction in early stages — a key factor of pre-eclampsia.
As the Ophthalmic Artery branches directly from the internal carotid artery, it allows for indirect monitoring of cerebral blood flow, which is difficult to access, enabling the early detection of potential cardiovascular disease. The expanded HeartAssist™ further supports maternal health by real-time monitoring of cardiovascular conditions during pregnancy.
Healthcare professional’s work efficiency is at the center of Samsung Medison’s innovation. Live ViewAssist™ automatically extracts up to 39 ultrasound cross-sectional images, provides automated annotations and measurement results for key parameters throughout the pregnancy cycle, and reduce diagnostic time.
The integrated QualityCheck feature automatically evaluates the quality of extracted images during fetal diagnosis, supporting consistency of diagnostic accuracy.
Jihyun Kim, Head of the CX group at Samsung Medison said: “The Upgraded HERA 20 is more than just an equipment enhancement but it’s a total solution designed to support women’s health across all life stages. By combining AI technology with the healthcare professional’s clinical experience, we aim to enhance diagnostic accuracy and reduce burdens, ultimately driving meaningful change in the healthcare field.”
